Aytu Biopharma (AYTU) Depreciation & Amortization (CF) (2010 - 2026)
Aytu Biopharma (AYTU) posted Depreciation & Amortization (CF) of $1.12 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 23.4% from $1.46 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Depreciation & Amortization (CF) came in at $3.93 million, down 26.9% from FY2025.
- Annual Depreciation & Amortization (CF) has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -15.6% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Depreciation & Amortization (CF) was $5.38 million in FY2025 (-20.0%), $6.73 million in FY2024 (-23.7%), $8.82 million in FY2023 (-13.1%) and $10.15 million in FY2022 (+10.3%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $803,000 in fiscal Q1 2026 to a high of $2.68 million in fiscal Q1 2022 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last 17 quarters, with an average decline of 24.7% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was fiscal Q2 2022, with growth of 43.0%; the weakest was fiscal Q1 2026, with a decline of 43.7%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $1.12 million (Q3 2026), $885,000 (Q2 2026) and $803,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 885,000.00 |
| Sep 30, 2025 | 803,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 2.21 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.68 Mn |
API Access
Aytu Biopharma Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();